The precise mechanism by which MB-2006 inhibits the NF-κB pathway in AD-like HaCaT keratinocyte cells involves multiple steps that culminate in a reduced inflammatory response characteristic of atopic dermatitis (AD) [32]. This evidence concerns the gene NFKB1 and atopic eczema.